FOI release

Innovator RMP apixaban (Eliquis)

This request was refused in part, so we didn't provide some of the information the requester asked for. This may include information where we can neither confirm nor deny that we hold it.

Case reference FOI2026/00550

Received 19 May 2026

Published 21 July 2026

Request

See attached

Response

See attached

Documents

• FOI2026_00550 (redacted).pdf (707.8 KB)
• risk-management-system-Eliquis (Apixaban)_Redacted.pdf (23.8 MB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.